QSAR Regression Models for Predicting HMG-CoA Reductase Inhibition
Open Access
- 30 October 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (11) , 1448
Abstract
Background/Objectives: HMG-CoA reductase is an enzyme that regulates the initial stage of cholesterol synthesis, and its inhibitors are widely used in the treatment of cardiovascular diseases. Methods: We have created a set of quantitative structure-activity relationship (QSAR) models for human HMG-CoA reductase inhibitors using nested cross-validation as the primary validation method. To develop the QSAR models, we employed various machine learning regression algorithms, feature selection methods, and fingerprints or descriptor datasets. Results: We built and evaluated a total of 300 models, selecting 21 that demonstrated good performance (coefficient of determination, R2 ≥ 0.70 or concordance correlation coefficient, CCC ≥ 0.85). Six of these top-performing models met both performance criteria and were used to construct five ensemble models. We identified the descriptors most important in explaining HMG-CoA inhibition for each of the six best-performing models. We used the top models to search through over 220,000 chemical compounds from a large database (ZINC 15) for potential new inhibitors. Only a small fraction (237 out of approximately 220,000 compounds) had reliable predictions with mean pIC50 values ≥ 8 (IC50 values ≤ 10 nM). Our svm-based ensemble model predicted IC50 values < 10 nM for roughly 0.08% of the screened compounds. We have also illustrated the potential applications of these QSAR models in understanding the cholesterol-lowering activities of herbal extracts, such as those reported for an extract prepared from the Iris × germanica rhizome. Conclusions: Our QSAR models can accurately predict human HMG-CoA reductase inhibitors, having the potential to accelerate the discovery of novel cholesterol-lowering agents and may also be applied to understand the mechanisms underlying the reported cholesterol-lowering activities of herbal extracts.Keywords
All Related Versions
Funding Information
- University of Medicine and Pharmacy Carol Davila
This publication has 138 references indexed in Scilit:
- Identification of potential natural product derivatives as CK2 inhibitors based on GA-MLR QSAR modeling, synthesis and biological evaluationMedicinal Chemistry Research, 2024
- Prediction reliability of QSAR models: an overview of various validation toolsArchives of Toxicology, 2022
- Integrated QSAR Models to Predict Acute Oral Systemic ToxicityMolecular Informatics, 2018
- Towards the design of 3-aminopyrazole pharmacophore of pyrazolopyridine derivatives as novel antioxidantsMedicinal Chemistry Research, 2017
- Discovery and quantitative structure–activity relationship study of lepidopteran HMG‐CoA reductase inhibitors as selective insecticidesPest Management Science, 2017
- Synthesis and Characterization of Novel N‐(Phenyl, Benzyl, Hetaryl)‐2‐([1,2,4]Triazolo[1,5‐c]Quinazolin‐2‐ylthio)Acetamides by Spectral Data, Antimicrobial Activity, Molecular Docking and QSAR StudiesJournal of Heterocyclic Chemistry, 2016
- Synthesis and Biological Evaluation of Gem‐Difluoromethylenated Statin Derivatives as Highly Potent HMG‐CoA Reductase InhibitorsChinese Journal of Chemistry, 2016
- Statin use and the risk of developing diabetes: a network meta‐analysisPharmacoepidemiology and Drug Safety, 2016
- Open-source machine learning: R meets WekaComputational Statistics, 2008
- QSAR Modeling of Bioconcentration Factor by theoretical molecular descriptorsQSAR & Combinatorial Science, 2003